Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)16-27
Number of pages12
JournalToxicology and Applied Pharmacology
Volume335
DOIs
StatePublished - Nov 15 2017
Externally publishedYes

ASJC Scopus Subject Areas

  • Toxicology
  • Pharmacology

Keywords

  • Acquired resistance
  • CRM1
  • EGFR
  • EMT
  • KRAS mutation
  • NSCLC

Cite this